A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
In patients with cystic fibrosis, IL-9 signalling is increased. The authors describe an inflammatory loop in which IL-9 produced by Th9 cells drives mast cells to produce IL-2, resulting in ILC2 cell activation, and show inhibition of this loop with blocking antibodies to IL-9 in a mouse model of pu...
Guardado en:
Autores principales: | Silvia Moretti, Giorgia Renga, Vasilis Oikonomou, Claudia Galosi, Marilena Pariano, Rossana G. Iannitti, Monica Borghi, Matteo Puccetti, Marco De Zuani, Carlo E. Pucillo, Giuseppe Paolicelli, Teresa Zelante, Jean-Christophe Renauld, Oxana Bereshchenko, Paolo Sportoletti, Vincenzina Lucidi, Maria Chiara Russo, Carla Colombo, Ersilia Fiscarelli, Cornelia Lass-Flörl, Fabio Majo, Gabriella Ricciotti, Helmut Ellemunter, Luigi Ratclif, Vincenzo Nicola Talesa, Valerio Napolioni, Luigina Romani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a5105499b234761b49ef00baa79cfac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
por: Rossana G. Iannitti, et al.
Publicado: (2016) -
Defective Glyoxalase 1 Contributes to Pathogenic Inflammation in Cystic Fibrosis
por: Marilena Pariano, et al.
Publicado: (2021) -
DNA damage and related modifier genes in Italian Cystic fibrosis patients
por: STERPONE,SILVIA, et al.
Publicado: (2009) -
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation.
por: Guglielmo Sorci, et al.
Publicado: (2011) -
ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia
por: W. Posch, et al.
Publicado: (2021)